HAE

HAE Other Income/Expenses (Net)

-$115.31MTTM · USD

Period ending:

HAE FY Other Income/Expenses (Net)USD
HAE FY Other Income/Expenses (Net)1991-03-31: -$157.30M1992-03-31: -$2.20M1993-03-31: -$1.80M1994-03-31: -$1.00M1995-03-31: $100.00K1996-03-31: $900.00K1997-03-31: $2.30M1998-03-31: -$26.50M1999-03-31: $969.00K2000-03-31: $3.25M2001-03-31: $3.91M2002-03-31: $2.06M2003-03-31: $1.13M2004-03-31: -$65.00K2005-03-31: -$102.00K2006-03-31: $7.86M2007-03-31: $9.59M2008-03-31: $7.02M2009-03-31: -$565.00K2010-03-31: -$2.01M2011-03-31: -$467.00K2012-03-31: $740.00K2013-03-31: -$6.54M2014-03-31: -$10.93M2015-03-31: -$9.38M2016-03-31: -$9.47M2017-03-31: -$8.10M2018-03-31: $3.48M2019-03-31: -$9.91M2020-03-31: -$16.20M2021-03-31: -$16.83M2022-03-31: -$17.12M2023-03-31: -$14.63M2024-03-31: -$13.02M2025-03-29: -$9.75M2026-03-28: -$113.37M$9.59M-$157.30M
1991-03-312026-03-28

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

HAE other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 36 observations from Mar 31, 1991 to Mar 28, 2026.

Haemonetics Corp Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-113,371,000
-9,746,000
-13,018,000
-14,630,000
-17,121,000
-16,834,000
-16,199,000
-9,912,000
3,475,000
-8,095,000
-9,474,000
-9,375,000
-10,926,000
-6,540,000
740,000
-467,000
-2,011,000
-565,000
7,015,000
9,591,000
7,864,000
-102,000
-65,000
1,128,000
2,057,000
3,906,000
3,254,000
969,000
-26,500,000
2,300,000
900,000
100,000
-1,000,000
-1,800,000
-2,200,000
-157,300,000

Compare other income/expenses (net)

All HAE financial metrics · HAE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.